BRIEF published on 05/03/2024 at 18:05, 6 months 19 days ago Bastide Le Confort Médical announces its capital in voting rights as of April 30, 2024 Voting Rights Financial Markets Preference Shares Ordinary Actions Bastide
BRIEF published on 04/30/2024 at 15:50, 6 months 22 days ago Groupe Bastide webinar for shareholders and investors on May 22, 2024 Investors Webinar Strategy Questions Bastide Group
BRIEF published on 04/08/2024 at 18:05, 7 months 14 days ago Bastide wins a major respiratory assistance contract in the United Kingdom United Kingdom NHS Bastide Respiratory Support Oxygen Therapy
PRESS RELEASE published on 04/08/2024 at 18:00, 7 months 14 days ago Respiratory care therapy: Bastide wins new United Kingdom region - EUR 10 million/year contract for a minimum of seven years Bastide appointed exclusive respiratory care operator in East of England by NHS, bringing €10 million yearly revenue. Further expansion expected Expansion NHS Bastide Respiratory Care East Of England
Published on 11/22/2024 at 23:55, 9 hours 28 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 53 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 18 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 53 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 30 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 28 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 23 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
